Xiaohan Zhou[Author] - Search Results

Year	Number of Results
2009	1
2012	1
2017	2
2018	3
2019	4
2020	9
2021	18
2022	21
2023	12
2024	5

1

A Pan-Cancer Analysis of CD161, a Potential New Immune Checkpoint.

Zhou X, Du J, Liu C, Zeng H, Chen Y, Liu L, Wu D. Zhou X, et al. Front Immunol. 2021 Jul 9;12:688215. doi: 10.3389/fimmu.2021.688215. eCollection 2021. Front Immunol. 2021. PMID: 34305920 Free PMC article.

2

Leveraging circulating microbiome signatures to predict tumor immune microenvironment and prognosis of patients with non-small cell lung cancer.

Zhou X, You L, Xin Z, Su H, Zhou J, Ma Y. Zhou X, et al. J Transl Med. 2023 Nov 10;21(1):800. doi: 10.1186/s12967-023-04582-w. J Transl Med. 2023. PMID: 37950236 Free PMC article.

3

Interstitial Fluid Behavior and Diseases.

Liu WT, Cao YP, Zhou XH, Han D. Liu WT, et al. Adv Sci (Weinh). 2022 Feb;9(6):e2100617. doi: 10.1002/advs.202100617. Epub 2022 Jan 2. Adv Sci (Weinh). 2022. PMID: 34978164 Free PMC article. Review.

4

Single-molecule counting applied to the study of GPCR oligomerization.

Milstein JN, Nino DF, Zhou X, Gradinaru CC. Milstein JN, et al. Among authors: zhou x. Biophys J. 2022 Sep 6;121(17):3175-3187. doi: 10.1016/j.bpj.2022.07.034. Epub 2022 Aug 3. Biophys J. 2022. PMID: 35927960 Free PMC article. Review.

5

GSTM3 enhances radiosensitivity of nasopharyngeal carcinoma by promoting radiation-induced ferroptosis through USP14/FASN axis and GPX4.

Chen Y, Feng Y, Lin Y, Zhou X, Wang L, Zhou Y, Lin K, Cai L. Chen Y, et al. Among authors: zhou x. Br J Cancer. 2024 Mar;130(5):755-768. doi: 10.1038/s41416-024-02574-1. Epub 2024 Jan 16. Br J Cancer. 2024. PMID: 38228715 Free PMC article.

6

Diverse regulated cell death modes predict the immune microenvironment and drug sensitivity in lung adenocarcinoma.

You L, Xin Z, Zhou X, Na F, Zhou J, Ying B. You L, et al. Among authors: zhou x. J Cell Physiol. 2023 Nov;238(11):2570-2585. doi: 10.1002/jcp.31109. Epub 2023 Oct 16. J Cell Physiol. 2023. PMID: 37842875

7

Novel directions of precision oncology: circulating microbial DNA emerging in cancer-microbiome areas.

You L, Zhou J, Xin Z, Hauck JS, Na F, Tang J, Zhou X, Lei Z, Ying B. You L, et al. Among authors: zhou x. Precis Clin Med. 2022 Feb 3;5(1):pbac005. doi: 10.1093/pcmedi/pbac005. eCollection 2022 Mar. Precis Clin Med. 2022. PMID: 35692444 Free PMC article. Review.

8

Immunogenetic polymorphisms predict therapeutic efficacy and survival outcomes in tumor patients receiving PD-1/PD-L1 blockade.

Xin Z, You L, Li J, Na F, Chen M, Song J, Bai L, Chen H, Zhai J, Zhou X, Zhou J, Ying B. Xin Z, et al. Among authors: zhou x. Int Immunopharmacol. 2023 Aug;121:110469. doi: 10.1016/j.intimp.2023.110469. Epub 2023 Jun 11. Int Immunopharmacol. 2023. PMID: 37311357 Free article.

9

Machine learning versus crop growth models: an ally, not a rival.

Zhang N, Zhou X, Kang M, Hu BG, Heuvelink E, Marcelis LFM. Zhang N, et al. Among authors: zhou x. AoB Plants. 2022 Dec 1;15(2):plac061. doi: 10.1093/aobpla/plac061. eCollection 2023 Feb. AoB Plants. 2022. PMID: 36751366 Free PMC article. Review.

10

Immune Check Point Inhibitors and Immune-Related Adverse Events in Small Cell Lung Cancer.

Hou W, Zhou X, Yi C, Zhu H. Hou W, et al. Among authors: zhou x. Front Oncol. 2021 Mar 18;11:604227. doi: 10.3389/fonc.2021.604227. eCollection 2021. Front Oncol. 2021. PMID: 33816235 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

68 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

68 results

Results by year